Literature DB >> 6699010

Induction of vascular smooth muscle alpha-isoactin expression in BC3H1 cells.

A R Strauch, P A Rubenstein.   

Abstract

An isoactin analysis was performed on L-[35S]cysteine labeled BC3H1 cells to determine if these smooth muscle-like cells synthesize vascular smooth muscle actin. Three different NH2-terminal peptides were identified on thin layer electrophoretograms of DNase I-purified and trypsin-digested BC3H1 cell actin. Results obtained from secondary digestion with thermolysin or Staphylococcus aureus V8 protease showed that the most acidic NH2-terminal peptide was derived from vascular smooth muscle alpha-isoactin. Treatment of cell monolayers with serum-free medium caused a 3-fold increase in the level of alpha-isoactin expression and a concomitant decrease in the level of non-muscle beta- and gamma-isoactin. Cell-cell contact was required for induction of alpha-isoactin, and the effects of serum depletion on isoactin expression and cell growth were reversible. The intensity of about 11 out of 500 polypeptide spots on two-dimensional gels of BC3H1 cell polypeptides also was influenced by the culture conditions. The finding that smooth muscle isoactin expression was coupled to cell growth conditions indicate the potential usefulness of BC3H1 cells in studies of isoactin expression and utilization during vascular smooth muscle development.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6699010

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Effects of omega-3 fatty acids on vascular smooth muscle cells: reduction in arachidonic acid incorporation into inositol phospholipids.

Authors:  N R Yerram; A A Spector
Journal:  Lipids       Date:  1989-07       Impact factor: 1.880

2.  Ability of adenovirus 5 E1A proteins to suppress differentiation of BC3H1 myoblasts correlates with their binding to a 300 kDa cellular protein.

Authors:  J S Mymryk; R W Lee; S T Bayley
Journal:  Mol Biol Cell       Date:  1992-10       Impact factor: 4.138

3.  Characterization of a continuous smooth muscle cell line derived from rabbit aorta.

Authors:  M Nachtigal; M L Nagpal; P Greenspan; S A Nachtigal; A Legrand
Journal:  In Vitro Cell Dev Biol       Date:  1989-10

4.  Fetal expression of muscle-specific isoactins in multiple organs of the Wistar-Kyoto rat.

Authors:  R Ariel Gomez; B C Sturgill; R L Chevalier; D G Boyd; J L Lessard; G K Owens; M J Peach
Journal:  Cell Tissue Res       Date:  1987-10       Impact factor: 5.249

5.  Expression of high and low molecular weight caldesmons during phenotypic modulation of smooth muscle cells.

Authors:  N Ueki; K Sobue; K Kanda; T Hada; K Higashino
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

6.  Muscle cell differentiation is associated with increased insulin receptor biosynthesis and messenger RNA levels.

Authors:  A Brunetti; B A Maddux; K Y Wong; I D Goldfine
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

7.  Culture of C2C12 and BC3H1 myogenic cells with iron-supplemented calf serum; rapid media screen.

Authors:  S B Sharp; M Lee; E Enriquez; A Ghebremedhin; P Momjian; S Kim; L Sunday; M Villalvazo; L S Carvajal; S Avari
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-11       Impact factor: 2.416

8.  Mitogens and protein synthesis inhibitors induce ornithine decarboxylase gene transcription through separate mechanisms in the BC3H1 muscle cell line.

Authors:  E N Olson; G Spizz
Journal:  Mol Cell Biol       Date:  1986-08       Impact factor: 4.272

9.  The development expression of the rat alpha-vascular and gamma-enteric smooth muscle isoactins: isolation and characterization of a rat gamma-enteric actin cDNA.

Authors:  K M McHugh; J L Lessard
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

10.  Cerebral microvascular smooth muscle in tissue culture.

Authors:  S A Moore; A R Strauch; E J Yoder; P A Rubenstein; M N Hart
Journal:  In Vitro       Date:  1984-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.